A 48-year-old woman presents to you for bilateral hearing loss, aural fullness, vertigo, nausea/vomiting, and tinnitus of two months’ duration.
Are Steroids the Best Treatment for AIED?
Although steroids are effective for many patients with autoimmune inner ear disease (AIED), there are still challenges in diagnosing the condition, mysteries behind what happens to the inner ear, and controversy over whether intratympanic injections help.
Migraine-Associated Dizziness Is Elusive to Diagnose
Although migraine headache and dizziness coexist in a sizable proportion of the general population, the interface between migraine and dizziness is not well understood, according to a panel of experts.
Bone-Anchored Hearing Aids Offer Viable Alternative to Standard Devices
Bone-anchored hearing aids (BAHA) provide many patients who can’t use standard hearing aids-for example, those with ear malformations or chronic infections-the potential to restore their hearing.
Collaboration Between Otolaryngologists and Audiologists Can Benefit Both
Philip Mark Brown, MD’s audiologist coworkers keep him apprised of the current state of the art regarding the available battery of audiologic tests.
Tinnitus Desensitization Treatment Shows Promising Clinical Data
An FDA-cleared, noninvasive treatment approach that utilizes neural stimulation to desensitize patients to the disturbing impact of tinnitus has achieved consistently positive results in a controlled clinical study in Australia.
Cochlear Implant Complications Are Rare-But Can Be Lethal
Cochlear implantation has become a safe procedure-and, as result of refinements in devices and surgical techniques, complications are atypical.
Older Antiepileptic Drugs May Prevent Noise-Induced Hearing Loss
Noise-induced hearing loss is a key challenge in otolaryngology today. Interestingly, an older class of antiepileptic drugs, T-type calcium blockers, may hold promise as preventive agents.
Meningitis Vaccine Leads to Greater Reduction in Ear Infections
Approximately 80% of children three years of age and younger are affected by otitis media, with treatment costs estimated at more than $5 billion per year.
Stem Cell and Genetic Therapies for Hair Cell-Related Hearing Loss
The remarkable new tools of the genomic generation have been used by researchers at the House Ear Institute in Los Angeles, Translational Genomics Research Institute in Phoenix, and the University of Antwerp, Belgium, to zero in on genes that cause presbycusis, or age-related hearing loss.